Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Cigna

The $18,000 breast biopsy: When having insurance costs you a bundle

When Dani Yuengling felt a lump in her right breast last summer, she tried to ignore it.

Tribune News Service

An $18,000 biopsy? Paying cash might have been cheaper than using her insurance

A hospital's cost calculator said her procedure would be $1,400 for patients without insurance. Instead, the bill was almost $18,000 and, her part was more than $5,000 — the balance of her deductible.

WEKU

What Are Whales Doing With Cigna

Someone with a lot of money to spend has taken a bearish stance on Cigna (NYSE:CI). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Humana Dips After Huge Earnings Beat; Centene Is Better Than Recession-Proof

Humana earnings flew past estimates, following Centene's Q2 beat. Centene's outlook may be even brighter if there's a recession.

Investors Business Daily

Looking At Cigna's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Cigna. Looking at options history for Cigna (NYSE:CI) we detected 13 strange trades.

Benzinga

Inside IBD 50: Breakout Stocks Struggle To Get Airborne

Several IBD 50 stocks that have recently broken out of bases are struggling to advance amid a sluggish overall market.

Investors Business Daily

UnitedHealth Earnings Beat; UNH Stock Clears Buy Point

UnitedHealth earnings easily beat Q2 estimates and raised guidance. UNH stock moved above a buy point.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Looking At Cigna's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Cigna. Looking at options history for Cigna (NYSE:CI) we detected 11 strange trades.

Benzinga

Stock Market Indexes Tumble Nearly 2% After Another Hot Inflation Report; Bank Earnings Disappoint

The producer price index jumped 11.3% in June from the same period a year ago.

Investors Business Daily

Dow Jones Higher, Nasdaq Tests This Potential Resistance Level; These IBD 50 Stocks Hit Buy Points

The Nasdaq gained over 2% on Thursday and is attempting to regain its 50-day line.

Investors Business Daily

Stock Market Indexes See More Green As Health Care Stocks Hit Buy Points

The major stock market indexes are near the highs of the day at midday.

Investors Business Daily

Here's How Much You Would Have Made Owning Cigna Stock In The Last 10 Years

Cigna (NYSE:CI) has outperformed the market over the past 10 years by 9.15% on an annualized basis producing an average annual return of 20.13%. Currently, Cigna has a market capitalization of $84.90 billion.

Benzinga

Morgan Stanley Upgrades Cigna On Humira Prospects

Cigna Corp (NYSE: CI) is poised to benefit from the launch of bioequivalent Humira in July 2023, according to Morgan Stanley.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022

Upgrades

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Attractive 'Growth at a Reasonable Price' Stocks to Buy Now

GARP is a strategy to blend the best parts of value and growth investing. It's particularly apt as it will allow investors to identify the top growth stocks trading at attractive valuations such as Cigna (CI), Freeport McMoran (FCX), and Micron (MU).

Benzinga

What 15 Analyst Ratings Have To Say About Cigna

Within the last quarter, Cigna (NYSE:CI) has observed the following analyst ratings:

Salon

Oz profits from insulin price gougers

Mehmet Oz specifically called out UnitedHealth and CVS for soaring prices — but he's heavily invested in both

StockNews.com

3 Attractive 'Growth at a Reasonable Price' Stocks to Buy Now

Growth stocks have been mired in a brutal bear market. However, a handful of stocks are quite cheap and continue to grow at an impressive rate. 3 such stocks that investors should consider buying are Cigna (CI), Micron (MU), and Freeport McMoran (FCX).

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Federal regulators probe Cigna’s pharmacy benefit manager, CVS Caremark, and others. What are they investigating?

Express Scripts, the pharmacy benefit manager that Cigna Corp. bought in 2018, is being investigated by the Federal Trade Commission for what regulators claim is influence over drug prices wielded by pharmacy benefit managers and transparent business practices.

Benzinga

Analyzing Cigna's Short Interest

Cigna's (NYSE:CI) short percent of float has fallen 6.8% since its last report. The company recently reported that it has 3.00 million shares sold short, which is 0.96% of all regular shares that are available for trading.

Benzinga

What Are Whales Doing With Cigna

Someone with a lot of money to spend has taken a bullish stance on Cigna (NYSE:CI). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Salon

When medical test costs suddenly change

Preventive care should be free under the ACA. An investigation found it doesn't always work that way in practice

WEKU

Cancer screenings like colonoscopies are supposed to be free. Hers cost $2,185

Preventive care, like screening colonoscopies, is supposed to be free of charge to patients under the Affordable Care Act. But some hospitals haven't gotten the memo.

Benzinga

$1000 Invested In Cigna 10 Years Ago Would Be Worth This Much

Cigna (NYSE:CI) has outperformed the market over the past 10 years by 7.87% on an annualized basis producing an average annual return of 19.99%. Currently, Cigna has a market capitalization of $86.15 billion.

Benzinga

14 Analysts Have This to Say About Cigna

Cigna (NYSE:CI) has observed the following analyst ratings within the last quarter:

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.